Early United States experience with liver donation after circulatory determination of death using thoraco-abdominal normothermic regional perfusion: A multi-institutional observational study.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
06 2022
Historique:
revised: 07 03 2022
received: 04 01 2022
accepted: 25 03 2022
pubmed: 2 4 2022
medline: 16 6 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

Mortality on the liver waitlist remains unacceptably high. Donation after circulatory determination of death (DCD) donors are considered marginal but are a potentially underutilized resource. Thoraco-abdominal normothermic perfusion (TA-NRP) in DCD donors might result in higher quality livers and offset waitlist mortality. We retrospectively reviewed outcomes of the first 13 livers transplanted from TA-NRP donors in the US. Nine centers transplanted livers from eight organ procurement organizations. Median donor age was 25 years; median agonal phase was 13 minutes. Median recipient age was 60 years; median lab MELD score was 21. Three patients (23%) met early allograft dysfunction (EAD) criteria. Three received simultaneous liver-kidney transplants; neither had EAD nor delayed renal allograft function. One recipient died 186 days post-transplant from sepsis but had normal presepsis liver function. One patient developed a biliary anastomotic stricture, managed endoscopically; no recipient developed clinical evidence of ischemic cholangiopathy (IC). Twelve of 13 (92%) patients are alive with good liver function at 439 days median follow-up; one patient has extrahepatic recurrent HCC. TA-NRP DCD livers in these recipients all functioned well, particularly with respect to IC, and provide a valuable option to decrease deaths on the waiting list.

Identifiants

pubmed: 35362152
doi: 10.1111/ctr.14659
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14659

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Organ Procurement and Transplantation Network (OPTN) National Donaton and Transplantation Data. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/. Accessed April 6, 2022.
Johnston CJC, Sherif AE, Oniscu GC. Transplantation of discarded livers: the complementary role of normothermic regional perfusion. Nat Commun. 2021;12(1):4471. https://doi.org/10.1038/s41467-021-24595-7
Croome KP, Lee DD, Keaveny AP, Taner CB. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors. Transplantation. 2016;100(12):2640-2647. https://doi.org/10.1097/TP.0000000000001483
Haque OJ, Roth EM, Fleishman A, Eckhoff DE, Khwaja K. Long-Term Outcomes of Early Experience in Donation After Circulatory Death Liver Transplantation: outcomes at 10 Years. Ann Transplant. 2021;26:e930243. https://doi.org/10.12659/AOT.930243
Kwong AJ, Kim WR, Lake JR, et al. OPTN/SRTR 2019 Annual Data Report: liver. Am J Transplant. 2021;21(2):208-315. https://doi.org/10.1111/ajt.16494
Croome KP, Lee DD, Perry DK, et al. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017;23(3):342-351. https://doi.org/10.1002/lt.24713
Axelrod DA, Dzebisashvilli N, Lentine KL, et al. National assessment of early biliary complications after liver transplantation: economic implications. Transplantation. 2014;98(11):1226-1235. https://doi.org/10.1097/TP.0000000000000197
Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893-2894.
Ausania F, White SA, Coates R, Hulme W, Manas DM. Liver damage during organ donor procurement in donation after circulatory death compared with donation after brain death. Br J Surg. 2013;100(3):381-386. https://doi.org/10.1002/bjs.9009
Antoine C, Jasseron C, Dondero F, Savier E. French National Steering Committee of Donors After Circulatory D. Liver Transplantation From Controlled Donors After Circulatory Death Using Normothermic Regional Perfusion: an Initial French Experience. Liver Transpl. 2020;26(11):1516-1521. https://doi.org/10.1002/lt.25818
Hessheimer AJ, Coll E, Torres F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2019;70(4):658-665. https://doi.org/10.1016/j.jhep.2018.12.013
Oniscu GC, Randle LV, Muiesan P, et al. In situ normothermic regional perfusion for controlled donation after circulatory death-the United Kingdom experience. Am J Transplant. 2014;14(12):2846-2854. https://doi.org/10.1111/ajt.12927
Ravaioli M, De Pace V, Comai G, et al. Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study. Transpl Int. 2018;31(11):1233-1244. https://doi.org/10.1111/tri.13311
Watson CJE, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19(6):1745-1758. https://doi.org/10.1111/ajt.15241
De Carlis L, De Carlis R, Muiesan P. Past, present, and future of donation after circulatory death in Italy. Updates Surg. 2019;71(1):7-9. https://doi.org/10.1007/s13304-019-00640-5
Minambres E, Suberviola B, Dominguez-Gil B, et al. Improving the Outcomes of Organs Obtained From Controlled Donation After Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion. Am J Transplant. 2017;17(8):2165-2172. https://doi.org/10.1111/ajt.14214
Dalle Ave AL, Shaw DM, Bernat JL. Ethical Issues in the Use of Extracorporeal Membrane Oxygenation in Controlled Donation After Circulatory Determination of Death. Am J Transplant. 2016;16(8):2293-2299. https://doi.org/10.1111/ajt.13792
Hoffman JRH, McMaster WG, Rali AS, et al. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion. J Heart Lung Transplant. 2021;40(11):1408-1418. https://doi.org/10.1016/j.healun.2021.06.022
Manara A, Shemie SD, Large S, et al. Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: a United Kingdom and Canadian proposal. Am J Transplant. 2020;20(8):2017-2025. https://doi.org/10.1111/ajt.15775
Ethics, Determination of Death, and Organ Transplantation in Normothermic Regional Perfusion (NRP) with Controlled Donation after Circulatory Determination of Death (cDCD): American College of Physicians Statement of Concern. https://www.acponline.org/acp_policy/policies/ethics_determination_of_death_and_organ_transplantation_in_nrp_2021.pdf. Accessed December 25, 2021.
Parent B, Moazami N, Wall S, et al. Ethical and logistical concerns for establishing NRP-cDCD heart transplantation in the United States. Am J Transplant. 2020;20(6):1508-1512. https://doi.org/10.1111/ajt.15772
“Lab MELD” calculator. https://optn.transplant.hrsa.gov/data/allocation-calculators/meld-calculator/ Accessed December 25, 2021.
Organ Procurement and Transplantation Network Policy 9: Allocation of Livers and Liver-Intestines. https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf. Accessed December 25, 2021.
Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943-949. https://doi.org/10.1002/lt.22091
Croome KP, Taner CB. Expanding Role of Donation After Circulatory Death Donors in Liver Transplantation. Clin Liver Dis. 2021;25(1):73-88. https://doi.org/10.1016/j.cld.2020.08.005
Seal JB, Bohorquez H, Reichman T, et al. Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors. Liver Transpl. 2015;21(3):321-328. https://doi.org/10.1002/lt.24071

Auteurs

Marty T Sellers (MT)

Department of Surgery, Emory University, Atlanta, Georgia, USA.
Tennessee Donor Services, Nashville, Tennessee, USA.

Ahmed Nassar (A)

Department of Surgery, Emory University, Atlanta, Georgia, USA.

Musab Alebrahim (M)

Department of Surgery, The Ohio State University, Columbus, Ohio, USA.

Kazunari Sasaki (K)

Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Surgery, Stanford University, Stanford, California, USA.

David D Lee (DD)

Department of Surgery, Loyola University, Chicago, Illinois, USA.

Humberto Bohorquez (H)

Department of Surgery, Ochsner School of Medicine, New Orleans, Louisiana, USA.

Robert M Cannon (RM)

Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Gennaro Selvaggi (G)

Department of Surgery, University of Miami, Miami, Florida, USA.

Nikole Neidlinger (N)

Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA.

William G McMaster (WG)

Department of Cardiac Surgery, Vanderbilt University, Nashville, Tennessee, USA.

Jordan R H Hoffman (JRH)

Department of Cardiac Surgery, Vanderbilt University, Nashville, Tennessee, USA.

Ashish S Shah (AS)

Department of Cardiac Surgery, Vanderbilt University, Nashville, Tennessee, USA.

Martin I Montenovo (MI)

Department of Surgery, Vanderbilt University, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH